JACOBS IAN SETH (President, CEO, CFO, Secretary) reported 1 transaction at LOMOND THERAPEUTICS HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/5/2024ACC: 0001213900-24-094680
DirectorOfficer10% Owner· President, CEO, CFO, Secretary
Since Feb 2022
-75K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
75K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−75K
Price / share
—
Trade value
—
% of position
30.0%
11/1/2024
250K→175K
Total
Net shares
−75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/1/2024 | J · J | −75K | — | — | 30.0% | 250K | 175K |
| Total | −75K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported